A systematic review of evidence-based treatment strategies for obsessive-compulsive disorder resistant to first-line pharmacotherapy.
CONCLUSION: Treatment-resistant OCD remains a significant challenge to psychiatrists. To date, the most effective strategy is the addition of antipsychotics (aripiprazole and risperidone) to SRIs; another effective strategy is CBT addition to medications. Other strategies, such as the switch to another first-line treatment or the switch to intravenous administration are promising but need further confirmation in double-blind studies. The addition of medications other than antipsychotics remains to be studied, as several negative studies exist and positive ones need confirmation (only 1 positive study).
PMID: 29278206 [PubMed - as supplied by publisher]
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G Tags: Curr Med Chem Source Type: research
More News: Abilify | Chemistry | Effexor | Invega | Obsessive Compulsive Disorder | Paroxetine | Paxil | Psychiatry | Psychotherapy | Risperdal Consta | Seroquel | Study | Yale | Zyprexa